secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001816590-26-000004
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

COMPASS Pathways secures $150M loan from Hercules Capital, $50M funded immediately
--------------------------------------------------------------------------------

- New $150M term loan facility with Hercules Capital; $50M drawn on Jan 5, 2026 (Tranche 1).
- Proceeds repay ~$31.1M existing debt; remaining funds for general corporate purposes.
- Interest rate of 9.75% or prime+2.75%; interest-only payments until Q1 2029, maturity Jan 5, 2031.
- Additional tranches up to $100M available upon clinical, FDA approval, and commercial milestones.
- Loan secured by personal property (excluding IP); prepayment penalties from 0.5% to 2.0%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659026000004/0001816590-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659026000004/cmps-20260105.htm
  HTML page:      https://secwatch.observer/filing/0001816590-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer